Roberts JA - Search Results

1

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.

Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, Hohn A, Weigand M, Michels G, Kluge S, Nierhaus A, Jarczak D, König C, Weismann D, Frey O, Witzke D, Müller C, Bauer M, Kiehntopf M, Neugebauer S, Lehmann T, Roberts JA, Pletz MW; TARGET Trial Investigators. Hagel S, et al. Among authors: roberts ja. Intensive Care Med. 2022 Mar;48(3):311-321. doi: 10.1007/s00134-021-06609-6. Epub 2022 Feb 1. Intensive Care Med. 2022. PMID: 35106617 Free PMC article. Clinical Trial.

2

Pharmacokinetic issues for antibiotics in the critically ill patient.

Roberts JA, Lipman J. Roberts JA, et al. Crit Care Med. 2009 Mar;37(3):840-51; quiz 859. doi: 10.1097/CCM.0b013e3181961bff. Crit Care Med. 2009. PMID: 19237886 Review.

3

Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?

Roberts JA, Roberts MS, Robertson TA, Dalley AJ, Lipman J. Roberts JA, et al. Among authors: roberts ms. Crit Care Med. 2009 Mar;37(3):926-33. doi: 10.1097/CCM.0b013e3181968e44. Crit Care Med. 2009. PMID: 19237898 Clinical Trial.

4

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.

Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J. Roberts JA, et al. Among authors: roberts ms. Int J Antimicrob Agents. 2010 Feb;35(2):156-63. doi: 10.1016/j.ijantimicag.2009.10.008. Epub 2009 Dec 16. Int J Antimicrob Agents. 2010. PMID: 20018492

5

Pharmacokinetic evaluation of piperacillin-tazobactam.

Hayashi Y, Roberts JA, Paterson DL, Lipman J. Hayashi Y, et al. Among authors: roberts ja. Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):1017-31. doi: 10.1517/17425255.2010.506187. Expert Opin Drug Metab Toxicol. 2010. PMID: 20636224 Review.

6

Antibiotic dosing in multiple organ dysfunction syndrome.

Ulldemolins M, Roberts JA, Lipman J, Rello J. Ulldemolins M, et al. Among authors: roberts ja. Chest. 2011 May;139(5):1210-1220. doi: 10.1378/chest.10-2371. Chest. 2011. PMID: 21540219 Review.

7

Therapeutic drug monitoring of antimicrobials.

Roberts JA, Norris R, Paterson DL, Martin JH. Roberts JA, et al. Br J Clin Pharmacol. 2012 Jan;73(1):27-36. doi: 10.1111/j.1365-2125.2011.04080.x. Br J Clin Pharmacol. 2012. PMID: 21831196 Free PMC article.

8

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.

Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R; RENAL Replacement Therapy Study Investigators. Roberts DM, et al. Among authors: roberts ms, roberts ja. Crit Care Med. 2012 May;40(5):1523-8. doi: 10.1097/CCM.0b013e318241e553. Crit Care Med. 2012. PMID: 22511133

9

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.

Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J. Dulhunty JM, et al. Among authors: roberts ja. Clin Infect Dis. 2013 Jan;56(2):236-44. doi: 10.1093/cid/cis856. Epub 2012 Oct 16. Clin Infect Dis. 2013. PMID: 23074313 Clinical Trial.

10

Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime.

Smith NL, Freebairn RC, Park MA, Wallis SC, Roberts JA, Lipman J. Smith NL, et al. Among authors: roberts ja. Crit Care Resusc. 2012 Dec;14(4):312-5. Crit Care Resusc. 2012. PMID: 23230881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,474 results

Search Page